NCT01755429

Brief Summary

This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2012

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2012

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 24, 2012

Completed
Last Updated

December 24, 2012

Status Verified

February 1, 2012

Enrollment Period

Same day

First QC Date

December 4, 2012

Last Update Submit

December 21, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in platelet count from baseline

    26 weeks

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The two identified Japanese patients with aHUS for which eculizumab treatment was initiated in 2011

You may qualify if:

  • Patient and/or legal guardian must be willing and able to give written informed consent and id the patient is not an adult and able to read and write, the patient is willing to give written informed assent
  • Eculizumab treatment initiated as personal importation for aHUS in 201

You may not qualify if:

  • Not Applicable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shinshu University School of Medicine

Matsumoto, Japan

Location

Tokyo Medical and Dental University

Tokyo, Japan

Location

MeSH Terms

Conditions

Atypical Hemolytic Uremic Syndrome

Condition Hierarchy (Ancestors)

Hemolytic-Uremic SyndromeUremiaKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesThrombotic MicroangiopathiesThrombocytopeniaBlood Platelet DisordersCytopenia

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2012

First Posted

December 24, 2012

Study Start

May 1, 2012

Primary Completion

May 1, 2012

Study Completion

July 1, 2012

Last Updated

December 24, 2012

Record last verified: 2012-02

Locations